新闻资讯
News Center

17

2019

-

04

A delegation led by Hua Yutao, Director of Chemical Drugs and Medical Devices Division of China Biotechnology Development Center of the Ministry of Science and Technology of the People's Republic of China, visited our company

Classification:


On the morning of March 28, a delegation led by Hua Yutao, the director of the Chemical Drugs and Medical Devices Division of the China Biotechnology Development Center of the Ministry of Science and Technology, Zhou Aiping, the head of the Legal Department of the Zhongshan Science and Technology Bureau, and Hu Ping, the head of the Economic Development and Science and Technology Information Bureau of the Torch Development Zone, visited our company for field investigation.
As a representative enterprise of the Torch Development Zone, Mr. Wang Shenglan, the general manager of our company, led the management team to participate in the reception and reported on the company's future development strategy and main difficulties. Subsequently, the inspection team visited the product exhibition hall and production workshop to learn more about the company's product production process, product structure, quality management, etc.
After listening to the work report, the inspection team fully encouraged and recognized the work and achievements of our company and placed expectations on them. It is hoped that the company will do a good job in quality management, continue to strengthen its independent innovation ability, improve its research and development level, and maintain a stable growth trend, seize the development opportunities of the construction of the Greater Bay Area of Guangdong, Hong Kong and Macao, and fully use the favorable policy of "going out" to make its business specialized, refined and strong.

 

 

 


The company was invited to participate in the press conference of epidemic prevention and control in Zhongshan

On the morning of March 2, the Information Office of Zhongshan Municipal People's Government organized the 38th press conference on epidemic prevention and control. Wang Shenglan, the chairman of the company, was invited to attend the press conference as a representative of key enterprises. At the press conference, Mr. Wang, with the theme of "actively fulfilling the mission and social responsibility of the biomedical enterprise", introduced the situation of the company's actively promoting the resumption of work and production, fulfilling the mission of the enterprise and the development goals of the enterprise under the premise of doing a good job in the anti-epidemic measures for employees.

MORE +

Common sense of enzyme-linked immunosorbent assay (ELISA) test

1、 Balance: Before operation, balance the reagent at room temperature for 30-60 minutes. 2、 Sampling: 1. The sample is serum: it is better to store the blood naturally for 1-2 hours, and then centrifuge with 3000 rmp for 15 minutes; 2. The sample is plasma: the blood sample collection tube containing anticoagulant must be used. After blood collection, the blood collection tube must be immediately inverted and mixed for 5-10 times. After a period of time, 3000 rmp centrifugation for 15 minutes; If it is detected within a few days, it can be placed in a refrigerator of 2-8 ℃; if it is to be stored, it can be placed in a low-temperature refrigerator of - 20 ℃; 3. After adding the sample, put it into the incubator in time. After adding the enzyme reagent, gently wipe the surface of the enzyme label plate with absorbent paper to absorb;

MORE +

Relationship between laboratory diagnostic methods of EB virus infection and nasopharyngeal carcinoma (brief introduction)

EB virus is an important DNA virus that infects human beings. There are many diseases related to EBV infection, especially nasopharyngeal carcinoma. With the development of modern molecular biology, the diagnosis of EBV infection has made rapid progress from principle to method. Due to the high operational requirements, expensive equipment and reagents, the application of pathogen detection is limited, so the immunoserological detection of EBV infection is the most commonly used method for NPC screening at present. The early diagnosis and clinical stage of NPC are of great significance to the curative effect of radiotherapy.

MORE +

Criteria for evaluating immunodiagnostic kits

1. Sensitivity The sensitivity of a diagnostic reagent has two different meanings: first, the sensitivity represents that the reagent has the ability to detect the minimum amount of substances to be tested; Secondly, sensitivity also indicates the positive detection ability of the reagent in the population or a large number of samples, that is, the degree of false negative. Sensitivity is the primary quality standard of diagnostic reagents. If the sensitivity of the reagent does not meet the standard, then the reagent is worthless.

MORE +

CONTACT

QR-CODE

QR-CODE

Copyright © 2023  Zhongshan Bio-tech Co.,Ltd All rights reserved  Business license  Powered by :www.300.cn Zhongshan  SEO